Leaflet AMBROXOL AL 30 30mg tablets

Product code:
W12767003
Quantity:
100
Indicated for:
respiratory disorders with viscous secretions
Route of administration:
oral
Substance:
ambroxol (mucolytic)
ATC
R05CB06 — Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Ambroxol is a mucolytic agent used to treat respiratory conditions characterized by excessive production of viscous mucus. It is indicated for acute and chronic bronchitis, asthma, chronic obstructive pulmonary disease (COPD), and other lung conditions involving difficulty in mucus clearance.

Ambroxol works by reducing mucus viscosity and stimulating the activity of cilia in the airways, facilitating expectoration. It is effective in relieving productive cough and improving breathing.

Additionally, ambroxol has anti-inflammatory and antioxidant properties, making it useful in reducing airway inflammation. In some cases, it is also used to alleviate sore throat pain due to its local anesthetic effect.

It is available in the form of tablets, syrup, oral solution, or inhalation, and is well-tolerated by most patients. Side effects are rare and may include nausea, stomach discomfort, or mild allergic reactions.

General data about AMBROXOL AL 30 30mg

Substance:
ambroxol
Date of latest medicines list:
01-07-2013
Product code:
W12767003
Concentration:
30mg
Pharmaceutical form:
tablets
Quantity:
100
Product type:
Generic medicine
Prescription status:
OTC — Over the Counter = medicine that does not require a medical prescription.

Marketing authorisation

Manufacturer:
STADA ARZNEIMITTEL AG - GERMANIA
Holder:
ALIUD PHARMA GMBH - GERMANIA
Number:
1643/2009/03
Shelf life:
4 years

Concentrations available for ambroxol

  • 0.3%
  • 0.75%
  • 15mg
  • 15mg/5ml
  • 15mg/ml
  • 20mg
  • 30mg
  • 30mg/5ml
  • 3mg/ml
  • 50mg/g
  • 60mg
  • 6mg/ml
  • 7.5mg/ml
  • 75mg